ResAppDx – Respiratory cough test

Summary: ResAppDx is Australia’s only TGA approved, clinically validated remote respiratory cough test. Developed by ResApp Health, ResAppDx analyses cough sounds using clinically validated algorithms to provide indications for lower respiratory tract disease, pneumonia, asthma/reactive airway disease exacerbations, COPD exacerbations, bronchiolitis and croup.

The product development went through a series of user flows, prototype testing and UI design iterations all based around a human-centered approach to ensure ResAppDx would be a success at being a function, useful and usable product. Working closely with iOS and Android developers as well as sound engineers.